These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4984423)

  • 1. [Rifomycin in treatment of tuberculosis with polyresistant mycobacteria: clinical and laboratory observations].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):442-9. PubMed ID: 4984423
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.
    Daniel TM
    N Engl J Med; 1969 Mar; 280(11):615-6. PubMed ID: 4974534
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifampicine in tuberculosis. Peculiarity of its experimental activity and new therapeutic prospects].
    Le Lirzin M; Grumbach F
    Pathol Biol (Paris); 1972 Oct; 20(19):785-92. PubMed ID: 4628424
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence and significance of positive fluorescent bacilloscopy associated with negative cultures during treatment based on isoniazid or rifomycin in tubercular patients treated in the sanatorium].
    Augier J; Parrot R; Gillet P
    Acta Tuberc Pneumol Belg; 1969; 60(3):417-29. PubMed ID: 4984422
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.
    Saerens EJ
    Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
    Erhard G
    Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and epidemiological characteristics of patients with drug-resistant tuberculosis].
    Okulovskaia SS; Gurevich GL; Bogomazova AV
    Probl Tuberk; 1999; (6):6-8. PubMed ID: 10715945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of therapeutic management of patients with pulmonary tuberculosis excreting tuberculous mycobacteria resistent to streptomycin and phthivazid].
    Vinnik LA
    Probl Tuberk; 1966; 44(6):23-7. PubMed ID: 4968673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin activity "in vitro" and in established tuberculosis in mice.
    Verbist L
    Acta Tuberc Pneumol Belg; 1969; 60(3):397-412. PubMed ID: 4984420
    [No Abstract]   [Full Text] [Related]  

  • 15. The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.
    Grosset JH; Baohong J; Ito T
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):807-13. PubMed ID: 3125288
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Shaĭkhaev AIa; Naumov VN
    Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.